Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Responsible Surgical Innovation: Natural Orifice Transluminal Endoscopic Surgery (NOTES)
Link ID 8203
Title Responsible Surgical Innovation: Natural Orifice Transluminal Endoscopic Surgery (NOTES)
Url http://www.medscape.com/viewarticle/579676?src=rss
Description NOTES: A model for systematic evaluation of new procedures
AccessMedicine from McGraw-Hill
Category Articles > Business of Medicine
Keywords
Date Aug 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Celgene Wins US Approval to Expand Vidaza Label
  Celgene Corp said on Thursday that U.S. regulators have given it the green light to add information to the label of its drug Vidaza showing it prolonged life in some patients with myelodysplastic syndromes, or MDS, a group of blood disorders that can lead to leukemia. Reuters Health Information
Category:   Articles > Business of Medicine


2. Mixing Music and Medicine
  A US citizen studying medicine in Mexico uses his blog to share his passion for music with the growing online community.
Medscape Med Students
Category:   Articles > Business of Medicine


3. U.S. Doctors Making Slow Shift to Digital Records
  Only a fraction of American doctors have switched from conventional paper records to electronic health records, with most citing cost as the biggest stumbling block, a national survey showed on Wednesday. Reuters Health Information
Category:   Articles > Business of Medicine


4. China Fake Drug Scandal Claims 14th Victim: Xinhua
  A batch of fake Chinese medicine claimed its 14th victim when a man died of kidney failure nearly two years after receiving a tainted injection, state media said. Reuters Health Information
Category:   Articles > Business of Medicine


5. Bristol-Myers Begins Cutting Jobs
  Bristol-Myers Squibb Co. said on Friday it has begun cutting jobs as part of a previously announced restructuring by the U.S. drugmaker meant to help bolster earnings growth. Reuters Health Information
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS